Send us Feedback

Hyperion (WAR:HYP)
Analysis
SUMMARY
BULLS
BEARS
QUOTE AND NEWS
Video Interview: Godfrey Sullivan, Chairman and Chief Executive Officer, Splunk Inc. [SPLK]
Globe Newswire  Apr 30  Comment 
NEW YORK, April 30, 2012 (GLOBE NEWSWIRE) -- Veteran business journalist Carmen Roberts joins Godfrey Sullivan, Chairman and Chief Executive Officer, Splunk Inc. [SPLK] to discuss the company's industry, strategy, financials and positioning. Click
Hyperion Exploration Corp. Announces 2011 Highlights, 2012 Operations Update, and Financial and Operating Results for the Year Ended December 31, 2011
Marketwire  Apr 26  Comment 
CALGARY, ALBERTA -- (Marketwire) -- 04/26/12 -- Hyperion Exploration Corp. ("Hyperion" or the "Corporation") (TSX VENTURE:HYX) is pleased to announce 2011 highlights, 2012 operations update, and financial and operating results for the year ended
Hyperion joins the growing IPO queue with $57M offering
FierceBiotech  Apr 16  Comment 
Hyperion Therapeutics is hoping that the prospect of its first drug launch will lure investors in on a $57 million IPO. Late last week Hyperion filed documents with the SEC outlining its plans to sell shares in the company, just a few months after...
Hyperion Therapeutics Files Registration Statement for Proposed Initial Public Offering
Business Wire  Apr 13  Comment 
Hyperion Therapeutics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares to be offered and the price range for
Hyperion Exploration Corp. Announces Significant Growth in 2011 Year End Reserves and Provides Operations Update
Marketwire  Mar 26  Comment 
CALGARY, ALBERTA -- (Marketwire) -- 03/26/12 -- Hyperion Exploration Corp. ("Hyperion" or the "Company") (TSX VENTURE:HYX) is pleased to provide information on the Company's 2011 year end reserves. Hyperion's reserves were evaluated by McDaniel &
Hyperion Therapeutics Acquires Ravicti From Ucyclyd Pharma
Benzinga  Mar 23  Comment 
Hyperion Therapeutics, Inc. today announced that it has acquired worldwide rights to the investigational drug Ravicti™ (glycerol phenylbutyrate) from Ucyclyd Pharma, Inc., a wholly owned subsidiary of Medicis Pharmaceutical Corporation (NYSE:...
Hyperion Power Generation Inc. Plans to Deploy an Advanced Hyperion Reactor at the DOE Savannah River Site
Business Wire  Mar 5  Comment 
Hyperion Power Generation Inc. (HPG), the Department of Energy – Savannah River (DOE-SR), and Savannah River National Laboratory (SRNL) have announced their commitment to deploy a privately-funded first-of-a-kind Hyperion reactor at the DOE
Hyperion Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
Business Wire  Feb 29  Comment 
Hyperion Therapeutics, Inc. today announced that Donald Santel, Chief Executive Officer, will present at the Cowen and Company 32nd Annual Health Care Conference on Monday, March 5, 2012 at 3:00 pm ET. The conference will be held at the Boston
BrightPoint Streamlines Global Financial Reporting With Oracle Hyperion
Cloud Computing  Feb 21  Comment 
Oracle (NASDAQ: ORCL) read more




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 


References

Retrieved from "http://www.wikinvest.com/stock/Hyperion_(WAR:HYP)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki